DK162604C - Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel - Google Patents

Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel

Info

Publication number
DK162604C
DK162604C DK447784A DK447784A DK162604C DK 162604 C DK162604 C DK 162604C DK 447784 A DK447784 A DK 447784A DK 447784 A DK447784 A DK 447784A DK 162604 C DK162604 C DK 162604C
Authority
DK
Denmark
Prior art keywords
purification
interferon
extraction
immune interferon
human immune
Prior art date
Application number
DK447784A
Other languages
English (en)
Other versions
DK447784A (da
DK162604B (da
DK447784D0 (da
Inventor
Susumu Honda
Hsiang-Fu Kung
Hiromu Sugino
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24128473&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK162604(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK447784D0 publication Critical patent/DK447784D0/da
Publication of DK447784A publication Critical patent/DK447784A/da
Publication of DK162604B publication Critical patent/DK162604B/da
Application granted granted Critical
Publication of DK162604C publication Critical patent/DK162604C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK447784A 1983-09-20 1984-09-19 Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel DK162604C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US53404083A 1983-09-20 1983-09-20
US53404083 1983-09-20

Publications (4)

Publication Number Publication Date
DK447784D0 DK447784D0 (da) 1984-09-19
DK447784A DK447784A (da) 1985-03-21
DK162604B DK162604B (da) 1991-11-18
DK162604C true DK162604C (da) 1992-05-11

Family

ID=24128473

Family Applications (1)

Application Number Title Priority Date Filing Date
DK447784A DK162604C (da) 1983-09-20 1984-09-19 Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel

Country Status (19)

Country Link
EP (1) EP0138087B1 (da)
JP (1) JP2592441B2 (da)
KR (1) KR940004544B1 (da)
AT (1) ATE33842T1 (da)
AU (1) AU590712B2 (da)
DE (1) DE3470747D1 (da)
DK (1) DK162604C (da)
ES (1) ES8606886A1 (da)
FI (1) FI80293C (da)
GB (1) GB2146998B (da)
GR (1) GR80405B (da)
HU (1) HU196461B (da)
IL (1) IL72986A (da)
MC (1) MC1627A1 (da)
NO (1) NO161274C (da)
NZ (1) NZ209588A (da)
PH (1) PH23241A (da)
PT (1) PT79232B (da)
ZA (1) ZA846554B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2164650A (en) * 1984-09-25 1986-03-26 Fujisawa Pharmaceutical Co Process for production of y-interferon
GB8508340D0 (en) * 1985-03-29 1985-05-09 Creighton T E Production of protein
DE19755960C1 (de) * 1997-12-16 1998-11-26 Hoechst Ag Verfahren zum Aufschluß von biologischem Material

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7404589A (nl) * 1974-04-03 1975-10-07 Stichting Rega V Z W Werkwijze voor het stabiliseren van interferon.
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
IL65475A0 (en) * 1981-04-17 1982-07-30 Meloy Lab Production of immune interferon and its mrna
IL63327A (en) * 1981-07-16 1985-11-29 Yeda Res & Dev Production of interferon beta1 and alpha-phage recombinants for its production in host bacteria
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
EP0088540A3 (en) * 1982-02-22 1984-10-17 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
IL69851A0 (en) * 1982-09-30 1983-12-30 Japan Found Cancer Novel dna and recombinant plasmid containing the same
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation
JPH0740925B2 (ja) * 1983-03-14 1995-05-10 協和醗酵工業株式会社 新規ヒトインタ−フエロン−γポリペプチド
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor

Also Published As

Publication number Publication date
FI843669A0 (fi) 1984-09-19
DK447784A (da) 1985-03-21
JPS6169800A (ja) 1986-04-10
ES536028A0 (es) 1986-05-16
MC1627A1 (fr) 1985-09-26
KR850002285A (ko) 1985-05-10
PT79232A (en) 1984-10-01
KR940004544B1 (en) 1994-05-25
GB2146998B (en) 1987-10-07
DE3470747D1 (en) 1988-06-01
GR80405B (en) 1985-01-21
HUT35289A (en) 1985-06-28
GB8423748D0 (en) 1984-10-24
DK162604B (da) 1991-11-18
HU196461B (en) 1988-11-28
FI80293C (fi) 1990-05-10
IL72986A (en) 1990-04-29
NO161274C (no) 1989-07-26
FI843669L (fi) 1985-03-21
EP0138087B1 (en) 1988-04-27
PT79232B (en) 1986-11-18
NO161274B (no) 1989-04-17
JP2592441B2 (ja) 1997-03-19
NO843750L (no) 1985-03-21
AU590712B2 (en) 1989-11-16
NZ209588A (en) 1989-05-29
ES8606886A1 (es) 1986-05-16
IL72986A0 (en) 1984-12-31
ZA846554B (en) 1985-04-24
FI80293B (fi) 1990-01-31
AU3330184A (en) 1985-03-28
PH23241A (en) 1989-06-06
ATE33842T1 (de) 1988-05-15
EP0138087A1 (en) 1985-04-24
GB2146998A (en) 1985-05-01
DK447784D0 (da) 1984-09-19

Similar Documents

Publication Publication Date Title
KR950700779A (ko) 단백질의 정제방법(Protein purification)
DK0620854T3 (da) Ekspression og oprensning af rekombinant opløselig vævsfaktor
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
DK430486A (da) Fremgangsmaade til udvinding af protein
DK447584D0 (da) Fremgangsmaade til rensning af immuninterferon
IT8247705A0 (it) Procedimento per la produzione di un anticorpo anti-proteina umana
DE69028513D1 (de) Träger zur bindung von antiphospholipid-antikörpern, diese antikörper verwendender immunotest und kit dafür
DK516485A (da) Fremgangsmaade til spaltning af peptider og proteiner ved methionyl-bindingen
DE68913251D1 (de) Verfahren zur Verringerung der Heterogenität von monoklonalen Antikörpern.
DK162604C (da) Fremgangsmaade til fremstilling af humant immuninterferon samt farmaceutiske praeparater indeholdende immuninterferon fremstillet ved fremgangsmaaden ifoelge opfindelsen og anvendelse af humant interferon fremstillet ved fremgangsmaaden ifoelge opfindelsen til fremstilling af et terapeutisk middel
ATE120492T1 (de) Fv antikörperfragment-herstellung.
NO874107L (no) Nye monoklonale antistoffer mot ifn-waa, fremgangsmaate til fremstilling derav og anvendelse for rensing samt paavisning av ifn-omega.
DK0401657T3 (da) Fremgangsmåde til C-terminal modificering af proteiner
ATE76082T1 (de) Reinigungsmethode fuer antikoerper.
IT1178489B (it) Vettore clonante, procedimento per la sua costruzione e procedimento di concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante

Legal Events

Date Code Title Description
PBP Patent lapsed